{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T02:20:10Z","timestamp":1788142810431,"version":"build-2803163510"},"reference-count":82,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Background\/Objectives: The administration of medicines via enteral feeding tubes presents unique challenges, including dose loss, tube blockage, and user-dependent variability. Although Quality by Design (QbD) frameworks provide a structured approach to product quality, administration-related quality attributes are rarely assessed in a systematic manner during pharmaceutical development. A conceptual framework, termed the Quality Target Administration Profile (QTAP), was developed to extend QbD principles to the administration stage. Methods: The framework comprises three phases: administration context characterization, administration attribute identification, and risk-based determination of Critical Administration Attributes (CAAs). QTAP was applied to three representative EFT administration scenarios: a ready-to-use oral suspension, a crushed tablet, and an oral solution. Results: Application of the framework identified 18\u201332 administration attributes across the three representative scenarios and prioritized 5\u20136 CAAs per scenario according to clinical impact, variability risk, and human-factor considerations. Administration quality requirements varied across scenarios, reflecting differences in administration context, including dosage form, patient population, clinical setting, and user characteristics. QTAP provides a structured approach for identifying and prioritizing administration-related quality considerations within pharmaceutical development. Conclusions: As a conceptual framework, QTAP is intended to complement rather than replace existing QbD approaches. Future prospective validation, including human-factor studies and real-world evaluations, is needed to establish its practical utility and predictive value.<\/jats:p>","DOI":"10.3390\/pharmaceutics18091089","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T02:08:58Z","timestamp":1788142138000},"page":"1089","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Introducing the Quality Target Administration (QTAP) Profile for Enteral Feeding Tube Medications"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3172-4645","authenticated-orcid":false,"given":"Smita","family":"Salunke","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics, School of Pharmacy, University College London, 29\/39 Brunswick Square, London WC1N 1AX, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8715-2614","authenticated-orcid":false,"given":"Chi Kin Anthony","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, School of Pharmacy, University College London, 29\/39 Brunswick Square, London WC1N 1AX, UK"},{"name":"Faculty of Pharmaceutical Sciences, KU Leuven, Herestraat 49, 3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1785-1981","authenticated-orcid":false,"given":"Sifan","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, School of Pharmacy, University College London, 29\/39 Brunswick Square, London WC1N 1AX, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,29]]},"reference":[{"key":"ref_1","unstructured":"Smith, T., Micklewright, A., Hirst, A., Stratton, R., and Baxter, J. (2011). Artificial Nutrition Support in the UK 2000\u20132010: A Report by the British Artificial Nutrition Survey (BANS), a Committee of BAPEN (The British Association for Parenteral and Enteral Nutrition), BAPEN."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.paed.2017.05.001","article-title":"Paediatric enteral tube feeding","volume":"27","author":"Burdall","year":"2017","journal-title":"Paediatr. Child Health"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1111\/apa.70199","article-title":"Challenges and Considerations in Manipulating Oral Dosage Forms in Paediatric Healthcare Settings: A Narrative Review","volume":"114","author":"Paulsson","year":"2025","journal-title":"Acta Paediatr."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Zahn, J., Hoerning, A., Trollmann, R., Rascher, W., and Neubert, A. (2020). Manipulation of Medicinal Products for Oral Administration to Paediatric Patients at a German University Hospital: An Observational Study. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12060583"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1046\/j.1365-2702.2001.00498.x","article-title":"Complications associated with enteral nutrition by nasogastric tube in an internal medicine unit","volume":"10","year":"2001","journal-title":"J. Clin. Nurs."},{"key":"ref_6","first-page":"250","article-title":"Compounding rifampin suspensions with improved injectability for nasogastric enteral feeding tube administration","volume":"14","author":"Vogel","year":"2010","journal-title":"Int. J. Pharm. Compd."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1177\/0018578717732340","article-title":"In Vitro Evaluation of Eslicarbazepine Delivery via Enteral Feeding Tubes","volume":"52","author":"Reindel","year":"2017","journal-title":"Hosp. Pharm."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"121286","DOI":"10.1016\/j.ijpharm.2021.121286","article-title":"A systematic approach for assessing the suitability of enteral feeding tubes for the administration of controlled-release pellet formulations","volume":"612","author":"Karkossa","year":"2022","journal-title":"Int. J. Pharm."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1080\/10837450.2021.1948567","article-title":"In vitro evaluation of enteral tube administration of lansoprazole orally disintegrating tablets","volume":"26","author":"Hoover","year":"2021","journal-title":"Pharm. Dev. Technol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/jpen.2490","article-title":"Developing guidance for feeding tube administration of oral medications","volume":"47","author":"Klang","year":"2023","journal-title":"J. Parenter. Enter. Nutr."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1111\/jgh.15484","article-title":"Diarrhea in tube-fed hospitalized patients: Feeding formula is not the most common cause","volume":"36","author":"Sripongpun","year":"2021","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ijpharm.2014.11.065","article-title":"Quantitative analysis of drug losses administered via nasogastric tube\u2014In vitro study","volume":"478","author":"Suk","year":"2015","journal-title":"Int. J. Pharm."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Thong, M.Y., Manrique, Y.J., and Steadman, K.J. (2018). Drug loss while crushing tablets: Comparison of 24 tablet crushing devices. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0193683"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/01.NAJ.0000361488.45094.28","article-title":"Drug administration through an enteral feeding tube","volume":"109","author":"Boullata","year":"2009","journal-title":"AJN Am. J. Nurs."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.2146\/ajhp080155","article-title":"Medication administration through enteral feeding tubes","volume":"65","author":"Williams","year":"2008","journal-title":"Am. J. Health-Syst. Pharm."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1111\/jocn.15498","article-title":"Survey of nurses\u2019 knowledge and practice regarding medication administration using enteral tubes","volume":"29","author":"Tillott","year":"2020","journal-title":"J. Clin. Nurs."},{"key":"ref_17","first-page":"A90","article-title":"G219\u2005Hydrocortisone tablets: Human factors in manipulation and their impact on dosing accuracy","volume":"103","author":"Watson","year":"2018","journal-title":"Arch. Dis. Child."},{"key":"ref_18","first-page":"99","article-title":"Handbook of Drug Administration via Enteral Feeding Tubes","volume":"71","author":"Phillips","year":"2007","journal-title":"Am. J. Pharm. Educ."},{"key":"ref_19","unstructured":"Wright, D.G.R., Merriman, H., Smithard, D., Smyth, J., and Welsh, N. (2021). Medication Management of Patients with NG, PEG or Other Feeding Tubes, North Yorkshire Clinical Commissioning Group. Available online: https:\/\/northyorkshireccg.nhs.uk\/wp-content\/uploads\/2021\/06\/MGP-guidelines-Medication-management-of-patients-with-NG-PEG-or-other-feeding-tubes.pdf."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Ayhan, Y.E., \u00d6zkanl\u0131, \u00d6.F., G\u00f6zelizmir, \u015e., Al-Taie, A., Sancar, M., and Midi, I. (2025). Impact of clinical pharmacist interventions on medication administration via enteral feeding tubes in a neurology ward: A pre- and post-educational prospective study. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1519835"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s11096-012-9673-8","article-title":"The role of clinical pharmacist to improve medication administration through enteral feeding tubes by nurses","volume":"34","author":"Badri","year":"2012","journal-title":"Int. J. Clin. Pharm."},{"key":"ref_22","unstructured":"European Medicines Agency (2026, July 07). Quality of Medicines Questions and Answers: Part 2. Administration of Oral Immediate Release Medicinal Products Through Enteral Feeding Tubes. Available online: https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/research-development\/scientific-guidelines\/quality-medicines-questions-answers-introduction\/quality-medicines-questions-answers-part-2."},{"key":"ref_23","unstructured":"Food and Drug Administration (2026, July 07). Oral Drug Products Administered via Enteral Feeding Tube: In Vitro Testing and Labeling Recommendations, Available online: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/oral-drug-products-administered-enteral-feeding-tube-in-vitro-testing-and-labeling-recommendations."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"115714","DOI":"10.1016\/j.addr.2025.115714","article-title":"Paediatric formulation challenges for enteral feeding tube administration\u2014Current understanding and future directions","volume":"227","author":"Hu","year":"2025","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_25","unstructured":"U.S Food and Drug Admnistration (2006). Quality Systems Approach to Pharmaceutical Current Good Manufacturing Practice Regulations, U.S Food and Drug Admnistration. Guidance for Industry."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s11095-007-9511-1","article-title":"Pharmaceutical Quality by Design: Product and Process Development, Understanding, and Control","volume":"25","author":"Yu","year":"2008","journal-title":"Pharm. Res."},{"key":"ref_27","unstructured":"Juran, J.M. (1992). Juran on Quality by Design: The New Steps for Planning Quality into Goods and Services, Simon and Schuster."},{"key":"ref_28","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) (2023). ICH Harmonised Guideline Q9(R1): Quality Risk Management, ICH. Available online: https:\/\/database.ich.org\/sites\/default\/files\/ICH_Q9%28R1%29_Guideline_Step4_2023_0126.pdf."},{"key":"ref_29","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) (2009). ICH Guideline Q8 (R2): Pharmaceutical Development, ICH. Available online: https:\/\/database.ich.org\/sites\/default\/files\/Q8_R2_Guideline.pdf."},{"key":"ref_30","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) (2008). ICH Harmonised Tripartite Guideline Q10: Pharmaceutical Quality System, ICH. Available online: https:\/\/database.ich.org\/sites\/default\/files\/Q10%20Guideline.pdf."},{"key":"ref_31","unstructured":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) (2009). Harmonised Tripartite Guideline: Pharmaceutical Development Q8 (R2), European Medicines Agency. Available online: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/international-conference-harmonisation-technical-requirements-registration-pharmaceuticals-human-use-considerations-ich-guideline-q8-r2-pharmaceutical-development-step-5_en.pdf."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Yang, S., Hu, X., Zhu, J., Zheng, B., Bi, W., Wang, X., Wu, J., Mi, Z., and Wu, Y. (2025). Aspects and Implementation of Pharmaceutical Quality by Design from Conceptual Frameworks to Industrial Applications. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17050623"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1208\/s12248-025-01079-w","article-title":"Rethinking Pharmaceutical Industry with Quality by Design: Application in Research, Development, Manufacturing, and Quality Assurance","volume":"27","author":"Duarte","year":"2025","journal-title":"AAPS J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/j.1552-4604.1991.tb03658.x","article-title":"Effects of Gravity on Gastric Emptying, Intestinal Transit, and Drug Absorption","volume":"31","author":"Amidon","year":"1991","journal-title":"J. Clin. Pharmacol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Gibson, M., Carmody, A., and Weaver, R. (2018). Development and Manufacture of Drug Product. Pharmaceutical Quality by Design, Wiley-Blackwell.","DOI":"10.1002\/9781118895238.ch6"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/ncp.10615","article-title":"Enteral Medication for the Tube-Fed Patient: Making This Route Safe and Effective","volume":"36","author":"Boullata","year":"2021","journal-title":"Nutr. Clin. Pract."},{"key":"ref_37","unstructured":"White, R., and Bradnam, V. (2015). Handbook of Drug Administration via Enteral Feeding Tubes, Pharmaceutical Press. [3rd ed.]."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3233\/NPM-1799","article-title":"Tube dependency as a result of prematurity","volume":"11","author":"Pahsini","year":"2018","journal-title":"J. Neonatal Perinat. Med."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Roumeliotis, N., Pullenayegum, E., Rochon, P., Taddio, A., and Parshuram, C. (2020). A modified Delphi to define drug dosing errors in pediatric critical care. BMC Pediatr., 20.","DOI":"10.1186\/s12887-020-02384-3"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Kim, K.S., Cho, H.J., Din, F.U., Cho, J.H., and Choi, H.G. (2025). Surfactant-Particle Engineering Hybrids: Emerging Strategies for Enhancing Solubility and Oral Bioavailability of Poorly Water-Soluble Drugs. Pharmaceutics, 18.","DOI":"10.3390\/pharmaceutics18010037"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/jps.21899","article-title":"Characterization of polymorph transformations that decrease the stability of tablets containing the WHO essential drug mebendazole","volume":"99","author":"Brits","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"123628","DOI":"10.1016\/j.ijpharm.2023.123628","article-title":"What to consider for successful administration of oral liquids via enteral feeding tubes? a case study with paediatric ibuprofen suspensions","volume":"649","author":"Karkossa","year":"2024","journal-title":"Int. J. Pharm."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s40266-023-01056-y","article-title":"Crushed Tablet Administration for Patients with Dysphagia and Enteral Feeding: Challenges and Considerations","volume":"40","author":"Blaszczyk","year":"2023","journal-title":"Drugs Aging"},{"key":"ref_44","first-page":"492","article-title":"Viscosity and flow-rate of three high-energy, high-fibre enteral nutrition formulas","volume":"24","year":"2009","journal-title":"Nutr. Hosp."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0261-5614(84)90019-0","article-title":"Flow and aspiration of artificial feeds through nasogastric tubes","volume":"2","author":"Elia","year":"1984","journal-title":"Clin. Nutr."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejpb.2023.08.013","article-title":"Navigating the complexities of medicating paediatric patients: Insights from an enteral feeding tube workshop","volume":"191","author":"Walsh","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1208\/s12248-024-00896-9","article-title":"Oral Drug Product Administration via Enteral Feeding Tubes: In Vitro Testing","volume":"26","author":"Wilson","year":"2024","journal-title":"AAPS J."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"8505","DOI":"10.3748\/wjg.v20.i26.8505","article-title":"Gastroenteric tube feeding: Techniques, problems and solutions","volume":"20","author":"Blumenstein","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_49","first-page":"361","article-title":"Maintaining the stability of furosemide tablets during enteral feeding tube delivery using PVC and non-PVC tubes, in accordance with hospital protocols","volume":"33","author":"Dantas","year":"2025","journal-title":"Eur. J. Hosp. Pharm."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/001857870403900308","article-title":"A Guide to Drug Therapy in Patients with Enteral Feeding Tubes: Dosage Form Selection and Administration Methods","volume":"39","author":"Beckwith","year":"2004","journal-title":"Hosp. Pharm."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e70427","DOI":"10.1111\/cts.70427","article-title":"Stability of Medications Administered via Enteral Feeding Tubes: A Systematic Review","volume":"19","author":"Alodat","year":"2026","journal-title":"Clin. Transl. Sci."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Larsen, J.A. (2023). Enteral Nutrition and Tube Feeding. Applied Veterinary Clinical Nutrition, Wiley-Blackwell.","DOI":"10.1002\/9781119375241.ch20"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"152","DOI":"10.18579\/jopcr\/v22.3.23.46","article-title":"Importance of Appropriate Medication Administration in Patients with Nasogastric Feeding Tube","volume":"22","author":"Rajkumar","year":"2023","journal-title":"J. Pharm. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/ncp.10959","article-title":"Choosing wisely: Enteral feeding tube selection, placement, and considerations before and beyond the procedure room","volume":"38","author":"Reddick","year":"2023","journal-title":"Nutr. Clin. Pract."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4037\/ccn2007.27.4.17","article-title":"Development of evidence-based guidelines and critical care nurses\u2019 knowledge of enteral feeding","volume":"27","author":"Bourgault","year":"2007","journal-title":"Crit. Care Nurse"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s40267-019-00698-6","article-title":"Reduce medication errors in tube feeding administration by establishing administration standards and standardizing operation procedures","volume":"36","author":"Yu","year":"2020","journal-title":"Drugs Ther. Perspect."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.nut.2006.07.004","article-title":"Formula delivery in patients receiving enteral tube feeding on general hospital wards: The impact of nasogastric extubation and diarrhea","volume":"22","author":"Whelan","year":"2006","journal-title":"Nutrition"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"101938","DOI":"10.1016\/j.jsps.2023.101938","article-title":"Unraveling medication errors in enteral tube administration: A cross-sectional study in geriatric patients receiving home health care","volume":"32","author":"Bifari","year":"2024","journal-title":"Saudi Pharm. J."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/jcpt.12664","article-title":"Carers\u2019 experiences of home enteral feeding: A survey exploring medicines administration challenges and strategies","volume":"43","author":"Alsaeed","year":"2018","journal-title":"J. Clin. Pharm. Ther."},{"key":"ref_60","first-page":"262","article-title":"Developmental pharmacokinetics in pediatric populations","volume":"19","author":"Lu","year":"2014","journal-title":"J. Pediatr. Pharmacol. Ther."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Patel, S., Huang, M., and Miliara, S. (2025). Understanding Treatment Adherence in Chronic Diseases: Challenges, Consequences, and Strategies for Improvement. J. Clin. Med., 14.","DOI":"10.3390\/jcm14176034"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1177\/0148607108330314","article-title":"Enteral nutrition practice recommendations","volume":"33","author":"Bankhead","year":"2009","journal-title":"J. Parenter. Enter. Nutr."},{"key":"ref_63","unstructured":"European Medicines Agency (EMA) (2021). Note for Guidance on In-Use Stability Testing of Human Medicinal Products (CPMP\/QWP\/2934\/99), European Medicines Agency (EMA)."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0169-8141(92)90042-X","article-title":"Design, selection and use of hand tools to alleviate trauma of the upper extremities: Part I\u2014Guidelines for the practitioner","volume":"10","author":"Mital","year":"1992","journal-title":"Int. J. Ind. Ergon."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/0148607109337257","article-title":"Warfarin bioavailability with feeding tubes and enteral formula","volume":"34","author":"Klang","year":"2010","journal-title":"J. Parenter. Enter. Nutr."},{"key":"ref_66","unstructured":"NPPG Executive Committee (2022). Administration of Medicines Using ENFit Syringes, Neonatal & Paediatric Pharmacists Group."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e012286","DOI":"10.1136\/bmjopen-2016-012286","article-title":"Effect of warning symbols in combination with education on the frequency of erroneously crushing medication in nursing homes: An uncontrolled before and after study","volume":"6","author":"Wijma","year":"2016","journal-title":"BMJ Open"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Galmarini, E., Marciano, L., and Schulz, P.J. (2024). The effectiveness of visual-based interventions on health literacy in health care: A systematic review and meta-analysis. BMC Health Serv. Res., 24.","DOI":"10.1186\/s12913-024-11138-1"},{"key":"ref_69","unstructured":"Hodson, L., Ovesen, J., Couch, J., Hirst, D., Lawson, C., Lentz, T.J., MacKenzie, B., Mead, K., and National Institute for Occupational Safety and Health (NIOSH) (2023). Managing Hazardous Drug Exposures: Information for Healthcare Settings, National Institute for Occupational Safety and Health (NIOSH). Report No.: DHHS (NIOSH) Publication No. 2023-130."},{"key":"ref_70","unstructured":"U.S. Pharmacopeial Convention (2026, July 07). General Chapter <800>: Hazardous Drugs\u2014Handling in Healthcare Settings. Available online: https:\/\/www.usp.org\/compounding\/general-chapter-hazardous-drugs-handling-healthcare."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s00228-024-03723-4","article-title":"Drug administration via feeding tubes-a procedure that carries risks: Systematic identification of critical factors based on commonly administered drugs in a cohort of stroke patients","volume":"80","author":"Sommerfeldt","year":"2024","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/SGA.0000000000000866","article-title":"A Scoping Review of Interventions to Reduce Feeding Tube-Related Medication Errors","volume":"48","author":"Stefanski","year":"2025","journal-title":"Gastroenterol. Nurs."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e002183","DOI":"10.1136\/bmjoq-2022-002183","article-title":"Impact of a quality improvement programme on the preparation and administration of medications via a nasoenteral feeding tube: 2014-2019 intervention study","volume":"12","author":"Pereira","year":"2023","journal-title":"BMJ Open Qual."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"e13275","DOI":"10.1111\/nicc.13275","article-title":"Effectiveness of a checklist for enteral medication administration: A randomized controlled trial","volume":"30","year":"2025","journal-title":"Nurs. Crit. Care"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1136\/qshc.2004.013524","article-title":"Quality improvement of oral medication administration in patients with enteral feeding tubes","volume":"15","author":"Cusell","year":"2006","journal-title":"Qual. Saf. Health Care"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4037\/ccn2022395","article-title":"Assessment of Good Practice Guidelines for Administration of Drugs via Feeding Tubes by a Clinical Pharmacist in the Intensive Care Unit","volume":"42","author":"Cavagna","year":"2022","journal-title":"Crit. Care Nurse"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1177\/00185787211024216","article-title":"In Vitro Assessment for Dose Preparation and Simulated Administration of Azithromycin Suspensions via Enteral Feeding Tubes","volume":"57","author":"Santangelo","year":"2022","journal-title":"Hosp. Pharm."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e70160","DOI":"10.1002\/jcph.70160","article-title":"Drug Administration via Enteral Feeding Tubes: A Landscape Analysis of Information in Drug Product Labeling","volume":"66","author":"Samuels","year":"2026","journal-title":"J. Clin. Pharmacol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/ncp.10009","article-title":"Enteral Feeding Tube Clogging: What Are the Causes and What Are the Answers? A Bench Top Analysis","volume":"33","author":"Garrison","year":"2018","journal-title":"Nutr. Clin. Pract."},{"key":"ref_80","unstructured":"FDA. Food and Drug Administration (2026, July 07). CDER Patient-Focused Drug Development Webpage, Available online: https:\/\/www.fda.gov\/drugs\/development-approval-process-drugs\/cder-patient-focused-drug-development."},{"key":"ref_81","unstructured":"Food and Drug Administration (FDA) (2020). Patient-Focused Drug Development: Collecting Comprehensive and Representative Input Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholders, Food and Drug Administration (FDA)."},{"key":"ref_82","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) (2020). ICH Reflection Paper on Proposed ICH Guideline Work to Advance Patient Focused Drug Development, ICH. Available online: https:\/\/admin.ich.org\/sites\/default\/files\/2021-06\/ICH_ReflectionPaper_PFDD_FinalRevisedPostConsultation_2021_0602.pdf."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/18\/9\/1089\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T02:10:55Z","timestamp":1788142255000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/18\/9\/1089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,29]]},"references-count":82,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["pharmaceutics18091089"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics18091089","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,29]]}}}